Changing prostaglandin E2 (PGE2) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE2 receptor EP2 and EP4
This study found that prostaglandin E2 signaling diminishes as endometriotic lesions progress, with EP2/EP4 inhibitors exacerbating endometriosis while metformin shows promise by enhancing PGE2 signaling.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (100)
- Abnormal Expression of Prostaglandins E2 and F2<i>α</i>Receptors and Transporters in Patients with Endometriosis via openalex
- Absence of aromatase protein and mRNA expression in endometriosis via openalex
- Analysis of cyclooxygenase-2 (COX-2) expression in different sites of endometriosis and correlation with clinico-pathological parameters via openalex
- An Analysis of <i>ESR2</i> and <i>CYP19A1</i> Gene Expression Levels in Women With Endometriosis via openalex
- A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice via openalex
- Cellular Changes Consistent With Epithelial–Mesenchymal Transition and Fibroblast-to-Myofibroblast Transdifferentiation in the Progression of Experimental Endometriosis in Baboons via openalex
- Changing prostaglandin E2 (PGE<sub>2</sub>) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE<sub>2</sub> receptor EP2 and EP4 via openalex
- COX-2 overexpression in peritoneal lesions is correlated with nonmenstrual chronic pelvic pain via openalex
- Cyclooxygenase-2 expression in deep endometriosis and matched eutopic endometrium via openalex
- Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK via openalex
- Diagnosing Deep Endometriosis Using Transvaginal Elastosonography via openalex
- Distribution of cyclooxygenase-2 in eutopic and ectopic endometrium in endometriosis and adenomyosis via openalex
- Evidence in Support for the Progressive Nature of Ovarian Endometriomas via openalex
- Fibrogenesis resulting from cyclic bleeding: the Holy Grail of the natural history of ectopic endometrium via openalex
- Higher fibrotic content of endometriotic lesions is associated with diminished prostaglandin E2 signaling via openalex
- Histological and Immunohistochemical Characterization of the Similarity and Difference Between Ovarian Endometriomas and Deep Infiltrating Endometriosis via openalex
- Hormonal Therapy Deregulates Prostaglandin-Endoperoxidase Synthase 2 (<i>PTGS2</i>) Expression in Endometriotic Tissues via openalex
- ID2 mediates the transforming growth factor-β1-induced Warburg-like effect seen in the peritoneum of women with endometriosis via openalex
- Identification of multiple and distinct defects in prostaglandin biosynthetic pathways in eutopic and ectopic endometrium of women with endometriosis via openalex
- Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis via openalex
- Increased Production of 17β-Estradiol in Endometriosis Lesions Is the Result of Impaired Metabolism via openalex
- Is it time for a paradigm shift in drug research and development in endometriosis/adenomyosis? via openalex
- Leptin, its receptor and aromatase expression in deep infiltrating endometriosis via openalex
- Metformin as a new therapy for endometriosis, its effects on both clinical picture and cytokines profile via openalex
- Metformin Inhibits<i>StAR</i>Expression in Human Endometriotic Stromal Cells via AMPK-Mediated Disruption of CREB-CRTC2 Complex Formation via openalex
- Metformin regresses endometriotic implants in rats by improving implant levels of superoxide dismutase, vascular endothelial growth factor, tissue inhibitor of metalloproteinase-2, and matrix metalloproteinase-9 via openalex
- Metformin regulates stromal-epithelial cells communication via Wnt2/β-catenin signaling in endometriosis via openalex
- Metformin Suppresses Interleukin (IL)-1β-Induced IL-8 Production, Aromatase Activation, and Proliferation of Endometriotic Stromal Cells via openalex
- Metformin Suppresses Prostaglandin E2-Induced Cytochrome P450 Aromatase Gene Expression and Activity via Stimulation of AMP-Activated Protein Kinase in Human Endometriotic Stromal Cells via openalex
- Molecular and preclinical basis to inhibit PGE <sub>2</sub> receptors EP2 and EP4 as a novel nonsteroidal therapy for endometriosis via openalex
- Nonsteroidal antiinflammatory drugs differentially suppress endometriosis in a murine model via openalex
- Platelets and Regulatory T Cells May Induce a Type 2 Immunity That Is Conducive to the Progression and Fibrogenesis of Endometriosis via openalex
- Platelets are an unindicted culprit in the development of endometriosis: clinical and experimental evidence via openalex
- Platelets drive smooth muscle metaplasia and fibrogenesis in endometriosis through epithelial–mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation via openalex
- Progressive development of endometriosis and its hindrance by anti-platelet treatment in mice with induced endometriosis via openalex
- Repurposing dichloroacetate for the treatment of women with endometriosis via openalex
- Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Induces Apoptosis of Human Endometriotic Cells through Suppression of ERK1/2, AKT, NFκB, and β-Catenin Pathways and Activation of Intrinsic Apoptotic Mechanisms via openalex
- Selective Inhibition of Prostaglandin E2 Receptors EP2 and EP4 Inhibits Adhesion of Human Endometriotic Epithelial and Stromal Cells Through Suppression of Integrin-Mediated Mechanisms1 via openalex
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 inhibits invasion of human immortalized endometriotic epithelial and stromal cells through suppression of metalloproteinases via openalex
- Selective inhibition of prostaglandin E2 receptors EP2 and EP4 modulates DNA methylation and histone modification machinery proteins in human endometriotic cells via openalex
- The effects of metformin and letrozole on endometriosis and comparison of the two treatment agents in a rat model via openalex
- The establishment of a mouse model of deep endometriosis via openalex
- The potential danger of COX-2 inhibitors via openalex
- Time to redefine endometriosis including its pro-fibrotic nature via openalex
- Transforming Growth Factor-β Induced Warburg-Like Metabolic Reprogramming May Underpin the Development of Peritoneal Endometriosis via openalex
- Up-Regulation of Cyclooxygenase-2 Expression and Prostaglandin E2 Production in Human Endometriotic Cells by Macrophage Migration Inhibitory Factor: Involvement of Novel Kinase Signaling Pathways via openalex
- Use of knockout transgenic mice in the study of endometriosis: insights from mice lacking β2-microglobulin and interleukin-12p40 via openalex
- Use of selective PGE2 receptor antagonists on human endometriotic stromal cells and peritoneal macrophages via openalex
- 'Waiting for Godot': a commonsense approach to the medical treatment of endometriosis via openalex
- W3085048027 via openalex
- W3135039241 via openalex
- W3162307163 via openalex
- W78459228 via openalex
- W4211081176 via openalex
- W122551365 via openalex
- W1710016801 via openalex
- W1738485982 via openalex
- W1968918707 via openalex
- W1969169755 via openalex
- W1970205234 via openalex
- W1981263394 via openalex
- W2031938767 via openalex
- W2039274017 via openalex
- W2049019160 via openalex
- W2050189717 via openalex
- W2051479586 via openalex
- W2089039380 via openalex
- W2100201127 via openalex
- W2109525253 via openalex
- W2116043657 via openalex
- W2120736394 via openalex
- W2121612337 via openalex
- W2126753352 via openalex
- W2133907923 via openalex
- W2138226825 via openalex
- W2159731793 via openalex
- W2160811299 via openalex
- W2171169752 via openalex
- W2172237567 via openalex
- W2336831152 via openalex
- W2411678126 via openalex
- W2508342609 via openalex
- W2561702225 via openalex
- W2582743722 via openalex
- W2587367335 via openalex
- W2594374473 via openalex
- W2622756604 via openalex
- W2742200852 via openalex
- W2770742412 via openalex
- W2781934183 via openalex
- W2782636435 via openalex
- W2800683872 via openalex
- W2809779343 via openalex
- W2811372969 via openalex
- W2886621746 via openalex
- W2895874809 via openalex
- W2909264327 via openalex
- W2912352885 via openalex
- W2955212273 via openalex
- W2955504961 via openalex
Cited by (19)
- <scp>IGF2BP1</scp> promotes endometriosis by enhancing <scp>m6A</scp> modification stability of <scp>HMGB1</scp> 2025
- Progressively diminished estrogen signaling concordant with increased fibrosis in ectopic endometrium 2025
- Drug development for adenomyosis based on pathophysiology 2025
- Endometriosis: recent advances that could accelerate diagnosis and improve care 2024
- The role of fibrosis in endometriosis: a systematic review 2024
- Adenomyosis and Abnormal Uterine Bleeding: Review of the Evidence 2024
- Progressively Diminished Prostaglandin E2 Signaling in Concordance with Increasing Fibrosis in Ectopic Endometrium 2024
- Endometriotic tissue fragments are viable after cryopreservation in an <i>ex vivo</i> tissue model recapitulating the fibrotic microenvironment 2024
- Digestive system deep infiltrating endometriosis: What do we know 2023
- The Role of Platelets in the Pathogenesis and Pathophysiology of Adenomyosis 2023
- Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis 2023
- (no title) 2023
- Advances in Metformin for Treatment of En-dometriosis 2023
- Aberrant expression of histone deacetylase 8 in endometriosis and its potential as a therapeutic target 2023
- Systematic review and meta-analysis of reproductive outcomes after high-intensity focused ultrasound (HIFU) treatment of adenomyosis 2023
- How does the extent of fibrosis in adenomyosis lesions contribute to heavy menstrual bleeding? 2022
- Age‐dependent phenotypes of ovarian endometriomas 2022
- Activation of α7 nicotinic acetylcholine receptor retards the development of endometriosis 2022
- Changing prostaglandin E2 (PGE<sub>2</sub>) signaling during lesional progression and exacerbation of endometriosis by inhibition of PGE<sub>2</sub> receptor EP2 and EP4 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-13T22:24:03.506079+00:00